The Food and Drug Administration has approved use of the first weekly transdermal skin patch for Alzheimer’s-related dementia. Adlarity (donepezil) is a patch for patients with mild, moderate or severe dementia and is available in 5- or 10-mg per day forms. The patch can be placed on the patient’s back, thigh or buttocks and will consistently deliver a well-tolerated dose […]